stella
beta
PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer — Stella
Recruiting
Back to Recurrent Non-Muscle Invasive Bladder Carcinoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
University of California Davis Comprehensive Cancer Center, Sacramento, California
View full record on ClinicalTrials.gov